about
Clinical impact of H-Y alloimmunityClinical efficacy of rituximab for acute rejection in kidney transplantation: a meta-analysis.The increasing clinical importance of alloantibodies in kidney transplantation.Off-label use of the expensive orphan drug eculizumab in France 2009-2013 and the impact of literature: focus on the transplantation field.Pre-transplant low level HLA antibody shows a composite poor outcome in long-term outcome of renal transplant recipients.Late kidney dysfunction in a kidney transplant recipient2016 Comprehensive Update of the Banff Working Group on Liver Allograft Pathology: Introduction of Antibody-Mediated Rejection.Determining donor-specific antibody C1q-binding ability improves the prediction of antibody-mediated rejection in human leucocyte antigen-incompatible kidney transplantation.
P2860
Q35235186-989CCDF5-0A32-4EF3-A279-844852AEF799Q38163419-B74F5CC7-EABC-4F5A-996F-3DDE702B22E1Q38258153-2639C474-74C5-42A2-9BDA-69A9A18A0F26Q39968188-992539DD-7EC3-412D-9D24-6C8CB804E3F9Q41615009-FD6E6283-0682-4D2C-AC1B-7D5AAF0025BEQ41834576-786302BB-9BDD-497C-B1E3-B516836844C2Q46360525-8AD8CC37-B6F6-40E8-8187-41E4106179FAQ48255248-24728BB7-2449-4F01-85A6-28D4F4186E5B
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Renal allograft pathology in the sensitized patient.
@en
type
label
Renal allograft pathology in the sensitized patient.
@en
prefLabel
Renal allograft pathology in the sensitized patient.
@en
P1476
Renal allograft pathology in the sensitized patient.
@en
P2093
Lynn D Cornell
P304
P356
10.1097/MOT.0B013E3283614C5A
P577
2013-06-01T00:00:00Z